Prageeth R. Wijewardhane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Prageeth R. Wijewardhane has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Gaurav Chopra
Department of Chemistry, Purdue University, West Lafayette, IN, USA
6 shared publications Jonathan Fine
Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States
3 shared publicationsMatthew Muhoberac
Purdue University 560 Oval Drive
3 shared publicationsCaitlin E. Randolph
Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States
2 shared publications- Aaron D. Gitler
Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
1 shared publication Adrienne Wells
Combat Wound Care Group, US Army Institute of Surgical Research
1 shared publication
Latest Publications
- 18 October 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (44) , 30122-30131
Instrument-Agnostic Machine Learning Framework for Accurate Prediction of Functional Groups from Tandem Mass Spectrometry
Structural elucidation of unknown compounds using tandem mass spectrometry (MS/MS) is an ongoing challenge. Expert chemists will often use common product ion peaks and neutral losses or peak matching software to predict structural aspects from MS/MS spectra, a process which is time consuming and limited by the molecular entries in the database. We introduce an instrument-agnostic machine learning (ML) framework that predicts functional groups directly from MS/MS spectra, eliminating the need for conventional database searches. The ML models are trained on data from different sources, the MassBank of North America (MONA), a public database, and a custom MS/MS database acquired using a single high throughput desorption electrospray ionization (DESI) MS/MS platform to showcase transferability of model predictions independent of instrument acquisition. Additionally, a novel spectral representation is developed for ML use by standardizing the spectra to the precursor ion m/z. We utilized molecular metrics, specifically, average molecular F1 score of 87% (MONA) and 76% (DESI) and average molecular accuracy of 94% (MONA) and 87% (DESI), indicating similar model performance when trained on different databases to validate the ML framework. To further illustrate the robustness and transferability of our ML framework, models trained on DESI-generated data successfully predicted functional groups, using spectral data generated from a blind test set of molecules using two different company laboratories using distinct mass spectrometry instruments (Orbitrap and TOF) operated in positive-ion mode electrospray ionization. We believe that such an approach, where models trained on data from one instrument can reliably make accurate predictions on spectra acquired using different instruments in a database-free manner, will significantly expand the practical applications of ML to mass spectrometry.
- 18 October 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (44) , 30122-30131
Instrument-Agnostic Machine Learning Framework for Accurate Prediction of Functional Groups from Tandem Mass Spectrometry
Structural elucidation of unknown compounds using tandem mass spectrometry (MS/MS) is an ongoing challenge. Expert chemists will often use common product ion peaks and neutral losses or peak matching software to predict structural aspects from MS/MS spectra, a process which is time consuming and limited by the molecular entries in the database. We introduce an instrument-agnostic machine learning (ML) framework that predicts functional groups directly from MS/MS spectra, eliminating the need for conventional database searches. The ML models are trained on data from different sources, the MassBank of North America (MONA), a public database, and a custom MS/MS database acquired using a single high throughput desorption electrospray ionization (DESI) MS/MS platform to showcase transferability of model predictions independent of instrument acquisition. Additionally, a novel spectral representation is developed for ML use by standardizing the spectra to the precursor ion m/z. We utilized molecular metrics, specifically, average molecular F1 score of 87% (MONA) and 76% (DESI) and average molecular accuracy of 94% (MONA) and 87% (DESI), indicating similar model performance when trained on different databases to validate the ML framework. To further illustrate the robustness and transferability of our ML framework, models trained on DESI-generated data successfully predicted functional groups, using spectral data generated from a blind test set of molecules using two different company laboratories using distinct mass spectrometry instruments (Orbitrap and TOF) operated in positive-ion mode electrospray ionization. We believe that such an approach, where models trained on data from one instrument can reliably make accurate predictions on spectra acquired using different instruments in a database-free manner, will significantly expand the practical applications of ML to mass spectrometry.
- 15 October 2025
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22 (11) , 6552-6560
Recurrent Neural Networks Predict Future Peptide Aggregation for Drug Development
Physical stability of an active pharmaceutical ingredient (API) is a key consideration in the development of a pharmaceutical drug. Solution conditions such as pH, excipient concentrations, and storage temperatures can impact the physical stability of a therapeutic peptide in formulation. Optimizing these conditions is a critical activity in achieving a higher stability of a therapeutic peptide product. A Thioflavin T (ThioT) fluorescent reporter assay is widely used to measure the aggregation of peptide products. ThioT kinetic assays are used to predict the propensity of fibril formation by using ThioT curves for a peptide stored in a solution. However, there is no analytical relationship that can be used to relate the physical stability for different formulation conditions, resulting in execution of large-scale stability assays that require significant resources for pharmaceutical companies. Therefore, there is a need to develop new artificial intelligence (AI) methods to predict future ThioT curves in a fast and cost-effective manner. Here, we combined an experimental measure of time-varying conformational states from ThioT assays with AI models to predict peptide aggregation in different formulation conditions during drug development. We formulated the peptide aggregation problem as "language translation" in natural language processing, wherein the sequence of aggregation states at earlier time points was used to predict (or "translate") the aggregation states for future time points. We developed a new sequence-to-sequence long short-term memory (LSTM)-based recurrent neural network (RNN) model to predict entire ThioT curves at future time points (6 and 12 months) using data sets from initial and 1 month ThioT curves for different conditions. We achieved an excellent average mean absolute error (MAE) of 2.04 for the model, which was used to predict and experimentally validate ThioT curves for a 6 month time point. In contrast to the LSTM, the multilayer perceptron (MLP) baseline model showed a higher MAE of 5.17. However, at the 12 month time point, with limited training data, both models achieved comparable results with average MAEs of 4.25 and 4.45 for LSTM and MLP, respectively. Therefore, we conclude that LSTM models can be used to predict future ThioT curves only using the initial and 1 month ThioT curves as input. We believe that the use of recurrent neural network models will benefit the pharmaceutical industry to predict and explore the formulation landscape for future physical stability measurements of APIs based on short-term stability data.
- 15 October 2025
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22 (11) , 6552-6560
Recurrent Neural Networks Predict Future Peptide Aggregation for Drug Development
Physical stability of an active pharmaceutical ingredient (API) is a key consideration in the development of a pharmaceutical drug. Solution conditions such as pH, excipient concentrations, and storage temperatures can impact the physical stability of a therapeutic peptide in formulation. Optimizing these conditions is a critical activity in achieving a higher stability of a therapeutic peptide product. A Thioflavin T (ThioT) fluorescent reporter assay is widely used to measure the aggregation of peptide products. ThioT kinetic assays are used to predict the propensity of fibril formation by using ThioT curves for a peptide stored in a solution. However, there is no analytical relationship that can be used to relate the physical stability for different formulation conditions, resulting in execution of large-scale stability assays that require significant resources for pharmaceutical companies. Therefore, there is a need to develop new artificial intelligence (AI) methods to predict future ThioT curves in a fast and cost-effective manner. Here, we combined an experimental measure of time-varying conformational states from ThioT assays with AI models to predict peptide aggregation in different formulation conditions during drug development. We formulated the peptide aggregation problem as "language translation" in natural language processing, wherein the sequence of aggregation states at earlier time points was used to predict (or "translate") the aggregation states for future time points. We developed a new sequence-to-sequence long short-term memory (LSTM)-based recurrent neural network (RNN) model to predict entire ThioT curves at future time points (6 and 12 months) using data sets from initial and 1 month ThioT curves for different conditions. We achieved an excellent average mean absolute error (MAE) of 2.04 for the model, which was used to predict and experimentally validate ThioT curves for a 6 month time point. In contrast to the LSTM, the multilayer perceptron (MLP) baseline model showed a higher MAE of 5.17. However, at the 12 month time point, with limited training data, both models achieved comparable results with average MAEs of 4.25 and 4.45 for LSTM and MLP, respectively. Therefore, we conclude that LSTM models can be used to predict future ThioT curves only using the initial and 1 month ThioT curves as input. We believe that the use of recurrent neural network models will benefit the pharmaceutical industry to predict and explore the formulation landscape for future physical stability measurements of APIs based on short-term stability data.
- Open Access
Modeling Molecular Mechanisms of Pirfenidone Interaction with Kinases
Scar formation is a process that occurs due to increased collagen deposition and uncontrolled inflammation. Previous studies have demonstrated that Pirfenidone (Pf), an FDA approved anti-inflammatory and anti-fibrotic drug can reduce inflammation in vivo as well as regulate activation of LPS-stimulated neutrophils. However, the molecular level mechanism of Pf’s action is not well understood. Here, we used neural networks to identify new targets and molecular modeling methods to investigate the Pf’s action pathways at the molecular level that are related to its ability to reduce both the inflammatory and remodeling phases of the wound healing process. Out of all the potential targets identified, both molecular docking and molecular dynamics results suggest that Pf has a noteworthy binding preference towards the active conformation of the p38 mitogen activated protein kinase-14 (MAPK14) and it is potentially a type I inhibitor-like molecule. In addition to p38 MAPK (MAPK14), additional potential targets of Pf include AKT1, MAP3K4, MAP2K3, MAP2K6, MSK2, MAP2K2, ERK1, ERK2, and PDK1. We conclude that several proteins/kinases, rather than a single target, are involved in Pf’s wound healing ability to regulate signaling, inflammation, and proliferation.
Open AccessModeling Molecular Mechanisms of Pirfenidone Interaction with Kinases
Scar formation is a process that occurs due to increased collagen deposition and uncontrolled inflammation. Previous studies have demonstrated that Pirfenidone (Pf), an FDA approved anti-inflammatory and anti-fibrotic drug can reduce inflammation in vivo as well as regulate activation of LPS-stimulated neutrophils. However, the molecular level mechanism of Pf’s action is not well understood. Here, we used neural networks to identify new targets and molecular modeling methods to investigate the Pf’s action pathways at the molecular level that are related to its ability to reduce both the inflammatory and remodeling phases of the wound healing process. Out of all the potential targets identified, both molecular docking and molecular dynamics results suggest that Pf has a noteworthy binding preference towards the active conformation of the p38 mitogen activated protein kinase-14 (MAPK14) and it is potentially a type I inhibitor-like molecule. In addition to p38 MAPK (MAPK14), additional potential targets of Pf include AKT1, MAP3K4, MAP2K3, MAP2K6, MSK2, MAP2K2, ERK1, ERK2, and PDK1. We conclude that several proteins/kinases, rather than a single target, are involved in Pf’s wound healing ability to regulate signaling, inflammation, and proliferation.
- Top Cited PapersOpen Access
- 21 February 2024
- Published by American Chemical Society (ACS) in ACS Measurement Science Au
- Vol. 4 (3) , 233-246
Recent Developments in Machine Learning for Mass Spectrometry
Statistical analysis and modeling of mass spectrometry (MS) data have a long and rich history with several modern MS-based applications using statistical and chemometric methods. Recently, machine learning (ML) has experienced a renaissance due to advents in computational hardware and the development of new algorithms for artificial neural networks (ANN) and deep learning architectures. Moreover, recent successes of new ANN and deep learning architectures in several areas of science, engineering, and society have further strengthened the ML field. Importantly, modern ML methods and architectures have enabled new approaches for tasks related to MS that are now widely adopted in several popular MS-based subdisciplines, such as mass spectrometry imaging and proteomics. Herein, we aim to provide an introductory summary of the practical aspects of ML methodology relevant to MS. Additionally, we seek to provide an up-to-date review of the most recent developments in ML integration with MS-based techniques while also providing critical insights into the future direction of the field.
- 21 February 2024
- Published by American Chemical Society (ACS) in ACS Measurement Science Au
- Vol. 4 (3) , 233-246
Top Cited PapersOpen AccessRecent Developments in Machine Learning for Mass Spectrometry
Statistical analysis and modeling of mass spectrometry (MS) data have a long and rich history with several modern MS-based applications using statistical and chemometric methods. Recently, machine learning (ML) has experienced a renaissance due to advents in computational hardware and the development of new algorithms for artificial neural networks (ANN) and deep learning architectures. Moreover, recent successes of new ANN and deep learning architectures in several areas of science, engineering, and society have further strengthened the ML field. Importantly, modern ML methods and architectures have enabled new approaches for tasks related to MS that are now widely adopted in several popular MS-based subdisciplines, such as mass spectrometry imaging and proteomics. Herein, we aim to provide an introductory summary of the practical aspects of ML methodology relevant to MS. Additionally, we seek to provide an up-to-date review of the most recent developments in ML integration with MS-based techniques while also providing critical insights into the future direction of the field.
- Open Access
Amyloid β Induces Lipid Droplet-Mediated Microglial Dysfunction in Alzheimer’s Disease
Summary: Several microglia-expressed genes have emerged as top risk variants for Alzheimer’s disease (AD). Impaired microglial phagocytosis is one of the main proposed outcomes by which these AD-risk genes may contribute to neurodegeneration, but the mechanisms translating genetic association to cellular dysfunction remain unknown. Here we show that microglia form lipid droplets (LDs) upon exposure to amyloid-beta (Aβ), and that their LD load increases with proximity to amyloid plaques in brains from human patients and the AD mouse model 5xFAD. LD formation is dependent on age and disease progression and is prominent in the hippocampus in mice and humans. Despite differences in microglial LD load between brain regions and sexes in mice, LD-laden microglia exhibited a deficit in Aβ phagocytosis. Unbiased lipidomic analysis identified a decrease in free fatty acids (FFAs) and a parallel increase in triacylglycerols (TGs) as the key metabolic transition underlying LD formation. DGAT2, a key enzyme for converting FFAs to TGs, promotes microglial LD formation and is increased in 5xFAD and human AD brains. Inhibition or degradation of DGAT2 improved microglial uptake of Aβ and drastically reduced plaque load in 5xFAD mice, respectively. These findings identify a new lipid-mediated mechanism underlying microglial dysfunction that could become a novel therapeutic target for AD.
Open AccessAmyloid β Induces Lipid Droplet-Mediated Microglial Dysfunction in Alzheimer’s Disease
Summary: Several microglia-expressed genes have emerged as top risk variants for Alzheimer’s disease (AD). Impaired microglial phagocytosis is one of the main proposed outcomes by which these AD-risk genes may contribute to neurodegeneration, but the mechanisms translating genetic association to cellular dysfunction remain unknown. Here we show that microglia form lipid droplets (LDs) upon exposure to amyloid-beta (Aβ), and that their LD load increases with proximity to amyloid plaques in brains from human patients and the AD mouse model 5xFAD. LD formation is dependent on age and disease progression and is prominent in the hippocampus in mice and humans. Despite differences in microglial LD load between brain regions and sexes in mice, LD-laden microglia exhibited a deficit in Aβ phagocytosis. Unbiased lipidomic analysis identified a decrease in free fatty acids (FFAs) and a parallel increase in triacylglycerols (TGs) as the key metabolic transition underlying LD formation. DGAT2, a key enzyme for converting FFAs to TGs, promotes microglial LD formation and is increased in 5xFAD and human AD brains. Inhibition or degradation of DGAT2 improved microglial uptake of Aβ and drastically reduced plaque load in 5xFAD mice, respectively. These findings identify a new lipid-mediated mechanism underlying microglial dysfunction that could become a novel therapeutic target for AD.
- Top Cited Papers
- 6 October 2021
- Published by Springer Nature in Nature
- Vol. 599 (7883) , 102-107
Neurotoxic reactive astrocytes induce cell death via saturated lipids
Astrocytes regulate the response of the central nervous system to disease and injury and have been hypothesized to actively kill neurons in neurodegenerative disease1,2,3,4,5,6. Here we report an approach to isolate one component of the long-sought astrocyte-derived toxic factor5,6. Notably, instead of a protein, saturated lipids contained in APOE and APOJ lipoparticles mediate astrocyte-induced toxicity. Eliminating the formation of long-chain saturated lipids by astrocyte-specific knockout of the saturated lipid synthesis enzyme ELOVL1 mitigates astrocyte-mediated toxicity in vitro as well as in a model of acute axonal injury in vivo. These results suggest a mechanism by which astrocytes kill cells in the central nervous system.
- 6 October 2021
- Published by Springer Nature in Nature
- Vol. 599 (7883) , 102-107
Top Cited PapersNeurotoxic reactive astrocytes induce cell death via saturated lipids
Astrocytes regulate the response of the central nervous system to disease and injury and have been hypothesized to actively kill neurons in neurodegenerative disease1,2,3,4,5,6. Here we report an approach to isolate one component of the long-sought astrocyte-derived toxic factor5,6. Notably, instead of a protein, saturated lipids contained in APOE and APOJ lipoparticles mediate astrocyte-induced toxicity. Eliminating the formation of long-chain saturated lipids by astrocyte-specific knockout of the saturated lipid synthesis enzyme ELOVL1 mitigates astrocyte-mediated toxicity in vitro as well as in a model of acute axonal injury in vivo. These results suggest a mechanism by which astrocytes kill cells in the central nervous system.